459.30 -0.25 (-0.05%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
457.65
Today’s High
462.5
52 Week Low
393.6
52 Week High
555.0
459.15 -0.35 (-0.08%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
457.6
Today’s High
462.5
52 Week Low
393.4
52 Week High
555
Key Metrics
- Market Cap (In Cr) 20270.84
- Beta 1.03
- Div. Yield (%) 1.74
- P/B 9.76
- TTM P/E 26.8
- Peg Ratio -2.13
- Sector P/E 58.51
- D/E 0.04
- Open Price 460.35
- Prev Close 459.55
Analysis
Price Analysis
-
1 Week5.95%
-
3 Months-6.62%
-
6 Month7%
-
YTD-11.46%
-
1 Year-14.15%
Risk Meter
- 29% Low risk
- 29% Moderate risk
- 29% Balanced Risk
- 29% High risk
- 29% Extreme risk
Recos
27 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 2
- Hold
- 4
- Buy
- 11
- Strong Buy
- 10
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 3192.03
- Selling/ General/ Admin Expenses Total
- 1097.1
- Depreciation/ Amortization
- 333.64
- Other Operating Expenses Total
- 24.62
- Total Operating Expense
- 2573.68
- Operating Income
- 618.35
- Net Income Before Taxes
- 688
- Net Income
- 838.98
- Diluted Normalized EPS
- 18.94
- Period
- 2022
- Total Assets
- 3057.48
- Total Liabilities
- 980.89
- Total Equity
- 2076.59
- Tangible Book Valueper Share Common Eq
- 33.8
- Period
- 2022
- Cashfrom Operating Activities
- 643.92
- Cashfrom Investing Activities
- -234.9
- Cashfrom Financing Activities
- -402.14
- Net Changein Cash
- 7.76
- Period
- 2021
- Total Revenue
- 2880.53
- Selling/ General/ Admin Expenses Total
- 1005.84
- Depreciation/ Amortization
- 365.85
- Other Operating Expenses Total
- 23.43
- Total Operating Expense
- 2356.39
- Operating Income
- 524.13
- Net Income Before Taxes
- 568.92
- Net Income
- 454.7
- Diluted Normalized EPS
- 10.25
- Period
- 2021
- Total Assets
- 2519.69
- Total Liabilities
- 757.04
- Total Equity
- 1762.65
- Tangible Book Valueper Share Common Eq
- 31.69
- Period
- 2021
- Cashfrom Operating Activities
- 921.53
- Cashfrom Investing Activities
- -226.95
- Cashfrom Financing Activities
- -688.18
- Net Changein Cash
- 8.97
- Period
- 2020
- Total Revenue
- 2654.88
- Selling/ General/ Admin Expenses Total
- 1021.33
- Depreciation/ Amortization
- 335.23
- Other Operating Expenses Total
- 27.88
- Total Operating Expense
- 2301.36
- Operating Income
- 353.52
- Net Income Before Taxes
- 373.57
- Net Income
- 302.91
- Diluted Normalized EPS
- 6.77
- Period
- 2020
- Total Assets
- 2678.48
- Total Liabilities
- 854.73
- Total Equity
- 1823.75
- Tangible Book Valueper Share Common Eq
- 26.56
- Period
- 2020
- Cashfrom Operating Activities
- 530.75
- Cashfrom Investing Activities
- -227.69
- Cashfrom Financing Activities
- -405.36
- Net Changein Cash
- -105.63
- Period
- 2019
- Total Revenue
- 2692.94
- Selling/ General/ Admin Expenses Total
- 984.17
- Depreciation/ Amortization
- 322.63
- Other Operating Expenses Total
- 25.92
- Total Operating Expense
- 2296.08
- Operating Income
- 396.86
- Net Income Before Taxes
- 403.41
- Net Income
- 303.23
- Diluted Normalized EPS
- 6.84
- Period
- 2019
- Total Assets
- 2822.37
- Total Liabilities
- 746.3
- Total Equity
- 2076.06
- Tangible Book Valueper Share Common Eq
- 26.41
- Period
- 2019
- Cashfrom Operating Activities
- 553.74
- Cashfrom Investing Activities
- -23.39
- Cashfrom Financing Activities
- -427.66
- Net Changein Cash
- 100.28
- Period
- 2018
- Total Revenue
- 2540.83
- Selling/ General/ Admin Expenses Total
- 943.63
- Depreciation/ Amortization
- 309.6
- Other Operating Expenses Total
- 29.2
- Total Operating Expense
- 2126.64
- Operating Income
- 414.19
- Net Income Before Taxes
- 393.77
- Net Income
- 307.14
- Diluted Normalized EPS
- 6.77
- Period
- 2018
- Total Assets
- 2800.74
- Total Liabilities
- 787.13
- Total Equity
- 2013.61
- Tangible Book Valueper Share Common Eq
- 22.12
- Period
- 2018
- Cashfrom Operating Activities
- 587.81
- Cashfrom Investing Activities
- -279.12
- Cashfrom Financing Activities
- -323.74
- Net Changein Cash
- -12.21
- Period
- 2017
- Total Revenue
- 2527.74
- Selling/ General/ Admin Expenses Total
- 886.95
- Depreciation/ Amortization
- 307.44
- Other Operating Expenses Total
- 27.54
- Total Operating Expense
- 2072.37
- Operating Income
- 455.37
- Net Income Before Taxes
- 423.62
- Net Income
- 340.42
- Diluted Normalized EPS
- 7.47
- Period
- 2017
- Total Assets
- 2603.16
- Total Liabilities
- 848.47
- Total Equity
- 1754.69
- Tangible Book Valueper Share Common Eq
- 11.07
- Period
- 2017
- Cashfrom Operating Activities
- 729.62
- Cashfrom Investing Activities
- -297.48
- Cashfrom Financing Activities
- -495.82
- Net Changein Cash
- -72.11
- Period
- 2022-09-30
- Total Revenue
- 813.75
- Selling/ General/ Admin Expenses Total
- 234.95
- Depreciation/ Amortization
- 47.93
- Other Operating Expenses Total
- 111.85
- Total Operating Expense
- 666.3
- Operating Income
- 147.45
- Net Income Before Taxes
- 185.52
- Net Income
- 184.18
- Diluted Normalized EPS
- 4.17
- Period
- 2022-09-30
- Total Assets
- 3173.44
- Total Liabilities
- 840.86
- Total Equity
- 2332.58
- Tangible Book Valueper Share Common Eq
- 39.15
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 278.25
- Cashfrom Investing Activities
- -72.44
- Cashfrom Financing Activities
- -193.81
- Net Changein Cash
- 10.15
- Period
- 2022-06-30
- Total Revenue
- 773.31
- Selling/ General/ Admin Expenses Total
- 225.09
- Depreciation/ Amortization
- 88.11
- Other Operating Expenses Total
- 88.81
- Total Operating Expense
- 688.1
- Operating Income
- 85.21
- Net Income Before Taxes
- 84.68
- Net Income
- 73.83
- Diluted Normalized EPS
- 1.67
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 770.39
- Selling/ General/ Admin Expenses Total
- 228.33
- Depreciation/ Amortization
- 83.46
- Other Operating Expenses Total
- 88.23
- Total Operating Expense
- 695.09
- Operating Income
- 75.3
- Net Income Before Taxes
- 97.84
- Net Income
- 355.96
- Diluted Normalized EPS
- 8.12
- Period
- 2022-03-31
- Total Assets
- 3057.48
- Total Liabilities
- 980.89
- Total Equity
- 2076.59
- Tangible Book Valueper Share Common Eq
- 33.8
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 643.92
- Cashfrom Investing Activities
- -234.9
- Cashfrom Financing Activities
- -402.14
- Net Changein Cash
- 7.76
- Period
- 2021-12-31
- Total Revenue
- 971.85
- Selling/ General/ Admin Expenses Total
- 230.6
- Depreciation/ Amortization
- 84.44
- Other Operating Expenses Total
- 82.72
- Total Operating Expense
- 714.75
- Operating Income
- 257.1
- Net Income Before Taxes
- 268.61
- Net Income
- 219.97
- Diluted Normalized EPS
- 4.94
- Period
- 2021-12-31
- Period
- 2021-12-31
- Period
- 2021-09-30
- Total Revenue
- 787.12
- Selling/ General/ Admin Expenses Total
- 187.39
- Depreciation/ Amortization
- 83.88
- Other Operating Expenses Total
- 77.89
- Total Operating Expense
- 593.82
- Operating Income
- 193.3
- Net Income Before Taxes
- 226.29
- Net Income
- 185.27
- Diluted Normalized EPS
- 4.17
- Period
- 2021-09-30
- Total Assets
- 2835.14
- Total Liabilities
- 775.3
- Total Equity
- 2059.84
- Tangible Book Valueper Share Common Eq
- 41.06
- Period
- 2021-09-30
- Cashfrom Operating Activities
- 290.84
- Cashfrom Investing Activities
- -301.62
- Cashfrom Financing Activities
- 24.04
- Net Changein Cash
- 13.11
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day464.26
- 10 Day447.49
- 20 Day451.84
- 50 Day472.25
- 100 Day475.05
- 300 Day464.66
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- P & G Hygiene & Health Care
- 14243
- 77.4
- 0.55
- 16466.4
- 12751
- 45902.08
- Colgate Palmolive India
- 1597.65
- -20.35
- -1.26
- 1695
- 1375.55
- 44004.56
- Emami
- 459.3
- -0.25
- -0.05
- 555
- 393.6
- 20270.84
- Gillette India
- 5154.95
- -11.4
- -0.22
- 5700.5
- 4751
- 16859.92
- Indiamart Intermesh
- 4475.3
- 10.15
- 0.23
- 7499
- 3676.05
- 13645.59
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- P & G Hygiene & Health Care
- 78.69
- 62.23
- 58.18
- 15.46
- Colgate Palmolive India
- 40.8
- 25.37
- 60.52
- 18.83
- Emami
- 24.26
- 9.76
- 23.01
- 15.78
- Gillette India
- 56.02
- 19.58
- 34.04
- 13.83
- Indiamart Intermesh
- 46.17
- 7.28
- 34.13
- 28.25
Shareholding
- Category
- Percentage
- No. of shares
- Promoter & Promoter Group Shareholding
- 54.27%
- 239,393,412
- SURAJ FINVEST
- 23.96%
- 105,720,226
- SNEHA ENCLAVE PRIVATE
- 22.37%
- 98,667,956
- MIDKOT INVESTMENTS PRIVATE LIMITED
- 0.71%
- 3,117,160
- EMAMI PAPER MILLS LTD
- 0.21%
- 933,000
- EMAMI FRANK ROSS LIMITED
- 0%
- 10,000
- PRITI A SUREKA
- 3.42%
- 15,104,702
- AVISHI SUREKA
- 0.32%
- 1,400,000
- SACHIN GOENKA
- 0.16%
- 717,000
- SHOBHANA AGARWAL
- 0.14%
- 630,000
- SASWAT GOENKA
- 0.13%
- 580,000
- VIBHASH VARDHAN AGARWAL
- 0.13%
- 573,478
- DARSH GOENKA
- 0.13%
- 565,000
- MANAN GOENKA
- 0.13%
- 565,000
- ADVAY GOENKA
- 0.13%
- 554,000
- JYOTI AGARWAL
- 0.11%
- 488,000
- DEVARSH GOENKA
- 0.09%
- 407,750
- REYANSH GOENKA
- 0.09%
- 407,750
- RADHESHYAM GOENKA
- 0.09%
- 400,876
- CHIKKY GOENKA
- 0.08%
- 371,700
- RACHANA GOENKA
- 0.07%
- 317,700
- RAJKUMAR GOENKA
- 0.07%
- 302,364
- SMRITI AGARWAL
- 0.07%
- 299,000
- RACHNA BAGARIA
- 0.06%
- 270,000
- INDU GOENKA
- 0.06%
- 269,700
- NIMISHA GOENKA
- 0.06%
- 244,000
- REHA GOENKA
- 0.05%
- 240,000
- SHREYA GOENKA
- 0.05%
- 230,000
- SAROJ GOENKA
- 0.05%
- 215,240
- ADITYA VARDHAN AGARWAL HUF
- 0.05%
- 204,278
- SHRUTI GOENKA
- 0.04%
- 196,130
- RADHESHYAM AGARWAL
- 0.04%
- 195,000
- PRASHANT GOENKA
- 0.04%
- 190,000
- SUSHIL KUMAR GOENKA HUF
- 0.04%
- 174,000
- MANISH GOENKA HUF
- 0.04%
- 174,000
- MOHAN GOENKA HUF
- 0.04%
- 174,000
- USHA AGARWAL
- 0.04%
- 173,096
- VIHAN VARDHAN AGARWAL
- 0.04%
- 172,000
- HARSHA VARDHAN AGARWAL HUF
- 0.04%
- 172,000
- ASHISH GOENKA
- 0.04%
- 169,400
- PUJA GOENKA
- 0.04%
- 169,398
- JAYANT GOENKA
- 0.04%
- 156,254
- MANSI AGARWAL
- 0.03%
- 150,000
- MANISH GOENKA
- 0.03%
- 142,196
- ADITYA VARDHAN AGARWAL
- 0.03%
- 134,668
- RASHMI GOENKA
- 0.03%
- 121,400
- LAXMI DEVI BAJORIA
- 0.03%
- 121,000
- SANTOSH GOENKA
- 0.03%
- 115,640
- SUSHIL KUMAR GOENKA
- 0.03%
- 114,300
- HARSHA VARDHAN AGARWAL
- 0.02%
- 110,266
- RICHA AGARWAL
- 0.02%
- 93,222
- VIDHISHREE AGARWAL
- 0.02%
- 80,000
- VIDULA AGARWAL
- 0.02%
- 80,000
- JAYANT GOENKA HUF
- 0.02%
- 74,000
- PRASHANT GOENKA HUF
- 0.02%
- 74,000
- ASHISH GOENKA HUF
- 0.02%
- 74,000
- MOHAN GOENKA
- 0.01%
- 61,900
- MADAN LAL AGARWAL
- 0.01%
- 60,000
- JYOTI GOENKA
- 0.01%
- 48,776
- KUSUM AGARWAL
- 0.01%
- 36,300
- PRADIP KUMAR AGARWAL
- 0.01%
- 31,150
- DIVYA AGARWAL
- 0.01%
- 26,000
- SANGITA AGARWAL
- 0.01%
- 26,000
- SHUBHAM AGARWAL
- 0.01%
- 24,460
- ABHISHEK AGARWAL
- 0.01%
- 24,000
- DHIRAJ AGARWAL
- 0%
- 16,750
- SUMANGAL AGARWAL
- 0%
- 8,200
- VISHAL AGARWAL
- 0%
- 8,200
- ROHIN RAJ SUREKA
- 0%
- 5,000
- AMITABH GOENKA
- 0.13%
- 571,496
- RITU GOENKA
- 0.1%
- 454,930
- NIKUNJ GOENKA
- 0.06%
- 265,000
- YOGESH GOENKA
- 0.06%
- 245,400
- AMITABH GOENKA HUF
- 0.02%
- 74,000
- Public Shareholding
- 45.73%
- 201,756,588
- DSP DYNAMIC ASSET ALLOCATION FUND
- 5.36%
- 23,623,999
- MIRAE ASSET BALANCED ADVANTAGE FUND
- 4.19%
- 18,479,927
- HDFC LARGE AND MID CAP FUND
- 2.98%
- 13,130,715
- L AND T MUTUAL FUND TRUSTEE LTD-L AND T FLEXICAP FUND
- 2.2%
- 9,712,488
- ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE NIFTY M
- 1.87%
- 8,243,682
- KOTAK DEBT HYBRID
- 1.78%
- 7,837,951
- FRANKLIN INDIA FOCUSED EQUITY FUND
- 1.58%
- 6,951,225
- NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA CAPITAL BUILDER FUND IV - SERIES
- 1.19%
- 5,237,697
- SBI CONSUMPTION OPPORTUNITIES FUND
- 1.04%
- 4,570,000
- Others
- 1.36%
- 6,145,863
- Others
- 10.83%
- 47,759,036
- Others
- 3.58%
- 15,793,477
- HDFC LIFE INSURANCE COMPANY LIMITED
- 1.96%
- 8,649,368
- Others
- 1.46%
- 6,436,620
- Others
- 3.13%
- 13,815,359
- Others
- 0.42%
- 1,856,879
- Others
- 0.31%
- 1,371,820
- Others
- 0.17%
- 752,614
- HUF
- 0.13%
- 581,427
- Clearing Members
- 0.03%
- 117,063
- Unclaimed or Suspense or Escrow Account
- 0.01%
- 30,574
- Trusts
- 0%
- 12,073
- Others
- 0.09%
- 375,341
- Others
- 0.03%
- 138,876
- Others
- 0.02%
- 69,576
- Others
- 0.01%
- 62,938
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 11-Nov-22
- Quarterly Results & Interim Dividend
- 29-Jul-22
- Quarterly Results
- 13-May-22
- Audited Results
- 03-Feb-22
- Qty Results, Int. Dividend & Buy Back
- 29-Oct-21
- Quarterly Results & Interim Dividend
- 02-Aug-21
- Quarterly Results
- 25-May-21
- Audited Results
- 27-Jan-21
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 28-Jun-22
- 25-May-22
- POM
- 29-Mar-22
- 24-Feb-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 18-Oct-22
- 21-Nov-22
- 18-Nov-22
- 4
- 17-Jan-22
- 11-Feb-22
- 10-Feb-22
- 4
- 18-Oct-21
- 09-Nov-21
- 08-Nov-21
- 4
- 18-Jan-21
- 05-Feb-21
- 04-Feb-21
- 4
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Emami
- Industry Personal & Household Prods.
- ISIN INE548C01032
- BSE Code 531162
- NSE Code EMAMILTD
Emami Limited is an India-based fast-moving consumer goods company (FMCG). The Company is engaged in the business of manufacturing and marketing personal care, healthcare and beauty products. The Company's product categories include cooling oils, balms, antiseptic cream, fairness creams for men and ayurvedic hair and scalp care oils. Its portfolio comprises of approximately 300 products. The Company's brand names include Boro Plus, Navratna, Fair and Handsome, Zandu Balm, Navratna, Kesh King, Zandu Pancharishta, fast relief, 7oils in one, Diamond shine, Emami golden beauty, Emami naturally fair, Emami Emasol, Creme21, Mentho Plus Balm, Dermicool and others. It also provides BoroPlus Organic Aloe Vera Gel, BoroPlus Hygiene range, EMASOL Home Hygiene range and various healthcare products under Zandu. Its subsidiaries include Emami Bangladesh Ltd., Emami International FZE, Emami Indo Lanka Pvt. Ltd, Emami Overseas FZE, Emami Rus LLC, Creme 21 GmbH and Pharmaderm Company SAE.
MANAGEMENT
- Harsha Agarwal Vice Chairman of the Board, Managing Director
- Mohan Goenka Vice Chairman of the Board, Whole Time Director
- Naresh Bhansali Chief Financial Officer, Chief Executive Officer - Finance, Strategy and Business Development
- Gul Bhatia President - Health Care Division
- Vivek Dhir Chief Executive Officer- International Business
- Punita Kalra Chief Executive Officer - Research and Innovation Strategy and Corporate Quality Assurance, CADE
- C. K. Katiyar Chief Executive Officer - Technical, Health Care
- Sanjay Madan President - Operations
- Pradeep Pandey President - Packaging
- Vinod Rao President - Sales, Consumer Care Division
Company Summary
EMAMI SUMMARY
Emami is trading 0.05% lower at Rs 459.30 as compared to its last closing price. Emami has been trading in the price range of 462.5 & 457.65. Emami has given -11.46% in this year & 5.95% in the last 5 days.
Emami has TTM P/E ratio 26.8 as compared to the sector P/E of 58.51. There are 27 analysts who have initiated coverage on Emami. There are 10 analysts who have given it a strong buy rating & 11 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of 184.18 Crores in its last quarter.
Listed peers of Emami include P & G Hygiene & Health Care (0.55%), Colgate Palmolive India (-1.26%), Emami (-0.05%) etc.
FAQs about Emami
Emami is trading at 459.30 as on 5 Dec, 2022 3:56:13 PM. This is -0.05% lower as compared to its previous closing price of 459.55
The market capitalization of Emami is 20270.84 Cr as on 5 Dec, 2022 3:56:13 PM.
The average broker rating on Emami is Buy. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 2 analysts have given a sell rating
- 4 analysts have given a hold rating
- 11 analysts have given a buy rating
- 10 analysts have given a strong buy rating
The 52 wk high for Emami is 555.0 whereas the 52 wk low is 393.6
Emami can be analyzed on the following key metrics -
- TTM P/E: 26.8
- Sector P/E: 58.51
- Dividend Yield: 1.74%
- D/E ratio: -
Emami reported a net profit of 838.98 Cr in 2022.
